Metabolic-Fit / 100
Goldspan Health review
Two things shape this listing more than the price does. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product instead links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each paired with B12. That storefront then advertises the price as monthly while stating that a new supply arrives automatically every four weeks, which means thirteen charges a year rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than a monthly reading implies. Both figures were already among the higher compounded rates here before that adjustment. What is on the credit side is real: a longevity platform with eleven protocol categories, medication dispensed through licensed 503A and 503B pharmacies, and a flat price at any dose. The fifty-state claim on the homepage is qualified by the terms, which say some therapies are unavailable in some states.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Goldspan Health at a glance
- Semaglutide
- $229 per 4 weeks
- Tirzepatide
- $299 per 4 weeks
- Coverage
- All 50 states claimed, with exceptions in the terms
- Brand-name
- Compounded only
How we scored Goldspan Health
Every factor comes from Goldspan Health's own published pricing, disclosures and oversight, and the six combine into the 31/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- September 2026
- Confidence
- medium
- Primary source
- goldspanhealth.com
Two things to know before the price, because both change what the price means. Goldspan publishes no figure anywhere on its own website — you have to follow a product link out to a separate storefront to learn that semaglutide is $229 and tirzepatide $299. And that storefront bills every four weeks while calling it monthly, so a year is thirteen charges rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than twelve payments would suggest. Both are already among the more expensive compounded options here. Medication is dispensed through licensed 503A and 503B pharmacies, and the fifty-state claim on the homepage is qualified by the terms.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $229 | Injection with B12, any dose⛔ Advertised as monthly but shipped and charged every 4 weeks — thirteen charges a year, about $2,977, not the $2,748 twelve payments would suggest. The price appears nowhere on Goldspan's own site; it is only on the separate storefront its product links lead to. |
| Compounded tirzepatide | $299 | Injection with B12, any dose⛔ Same 4-week cycle: about $3,887 a year across thirteen charges rather than $3,588. Also priced only on the third-party storefront. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Goldspan Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- A flat price at any dose, so titrating up does not raise the bill
- Medication dispensed through licensed 503A and 503B pharmacies
- Sits inside a broad longevity platform of eleven protocol categories if you want more than a GLP-1
- Both weight-loss protocols pair the molecule with B12 rather than selling it bare
The caveats
- No price appears anywhere on Goldspan's own site — you must click out to a third-party storefront
- Billed every 4 weeks while advertised as monthly, which is thirteen charges a year rather than twelve
- The real annual cost is about $2,977 and $3,887, not the $2,748 and $3,588 a monthly reading suggests
- Among the more expensive compounded GLP-1s on this list even before the cycle adjustment
- The homepage claims 50 states while the terms carve out exceptions
- Nothing on the site addresses pregnancy, breastfeeding or postpartum timing
Goldspan Health for mothers: our verdict
Two things shape this listing more than the price does. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product instead links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each paired with B12. That storefront then advertises the price as monthly while stating that a new supply arrives automatically every four weeks, which means thirteen charges a year rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than a monthly reading implies. Both figures were already among the higher compounded rates here before that adjustment. What is on the credit side is real: a longevity platform with eleven protocol categories, medication dispensed through licensed 503A and 503B pharmacies, and a flat price at any dose. The fifty-state claim on the homepage is qualified by the terms, which say some therapies are unavailable in some states. It runs about $229/4 weeks, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh Goldspan Health the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Goldspan Health costs, in full
- Compounded semaglutide — Injection with B12, any dose: $229/4 wks
- Compounded tirzepatide — Injection with B12, any dose: $299/4 wks
For context, the typical ongoing price across our roster is around $179/month, so Goldspan Health sits at the premium end.
Goldspan Health says the price covers the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Goldspan Health prescribes
Goldspan Health prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Goldspan Health fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Goldspan Health is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone already buying peptide protocols who wants a GLP-1 on the same platform, and who will do the thirteen-payment arithmetic before comparing it with a monthly seller.
Alternatives to Goldspan Health
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Goldspan Health
Head-to-head & alternatives
Goldspan Health, answered
- Why can I not find a price on Goldspan's website?
- Because there is not one. Its homepage and weight-loss category page carry no dollar figure at all. Every product links out to a separate storefront on another domain, and only there does a price appear — $229 for semaglutide and $299 for tirzepatide, both with B12. Buying from one company through another company's checkout is worth knowing about before you start.
- What does "every 4 weeks" cost me?
- About one extra payment a year. The storefront advertises the price as monthly but states that a new supply arrives automatically every four weeks, which is thirteen shipments in a year rather than twelve. Semaglutide works out to roughly $2,977 a year instead of $2,748, and tirzepatide to about $3,887 instead of $3,588 — around $230 and $300 more than a monthly reading suggests.
- Is Goldspan available everywhere?
- Not quite, by its own account. The homepage says "In 50 states", and the terms then say some therapies are unavailable in certain states. The claim and the qualification sit in different documents, so check that the specific protocol you want is offered where you live rather than relying on the headline.
Pricing, states and verification reflect Goldspan Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.